Yasuhiro Yamauchi to Transforming Growth Factor beta
                            
                            
                                This is a "connection" page, showing publications Yasuhiro Yamauchi has written about Transforming Growth Factor beta.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.261
         
        
        
     
 
    
        
        - 
            Noguchi S, Yamauchi Y, Takizawa H. Novel therapeutic strategies for fibrotic lung disease: a review with a focus on epithelial-mesenchymal transition. Recent Pat Inflamm Allergy Drug Discov. 2014 Jan; 8(1):9-18.
            
            
                Score: 0.104
             
- 
            Kamitani S, Yamauchi Y, Kawasaki S, Takami K, Takizawa H, Nagase T, Kohyama T. Simultaneous stimulation with TGF-?1 and TNF-a induces epithelial mesenchymal transition in bronchial epithelial cells. Int Arch Allergy Immunol. 2011; 155(2):119-28.
            
            
                Score: 0.084
             
- 
            Mikami Y, Matsuzaki H, Takeshima H, Makita K, Yamauchi Y, Nagase T. Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition. J Vis Exp. 2016 06 10; (112).
            
            
                Score: 0.031
             
- 
            Mikami Y, Yamauchi Y, Horie M, Kase M, Jo T, Takizawa H, Kohyama T, Nagase T. Tumor necrosis factor superfamily member LIGHT induces epithelial-mesenchymal transition in A549 human alveolar epithelial cells. Biochem Biophys Res Commun. 2012 Nov 30; 428(4):451-7.
            
            
                Score: 0.024
             
- 
            Asai K, Foley SC, Sumi Y, Yamauchi Y, Takeda N, Desrosiers M, Lavigne F, Hamid Q. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis. Allergol Int. 2008 Dec; 57(4):377-81.
            
            
                Score: 0.018